BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 5718833)

  • 1. [On some aspects of therapy of chronic peripheral obliterating arteriopathies (C.P.O.A.) on arteriosclerotic nature].
    Seghezzi R; Borri P; Pedroni G
    Minerva Med; 1968 Dec; 59(99):5458-65. PubMed ID: 5718833
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of a long-acting vasodilator agent in chronic peripheral obliterating arteriopathy of a sclerotic nature].
    Gemma GB; Ghezzi P; Cavaliere P
    Minerva Cardioangiol; 1969 May; 17(5):324-32. PubMed ID: 5785730
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanographic evaluation of peripheral hemodynamic effects of medico-surgical treatment in chronic obliterating arteriopathies].
    Warembourg H; Lekieffre J; Dupuis B; Vasseur P
    Angeiologie; 1970; 22(2):115-22. PubMed ID: 5448497
    [No Abstract]   [Full Text] [Related]  

  • 4. [Further trials of a long-acting vasodilator agent in 397 patients with cronic peripheral obliterating arteriopathy of a sclerotic nature].
    Ghezzi P; Cavaliere P; Berti Riboli E
    Minerva Cardioangiol; 1969 May; 17(5):333-6. PubMed ID: 5785731
    [No Abstract]   [Full Text] [Related]  

  • 5. [Conservative therapy of arterial occlusion disease].
    Dembowski U; Nielsen A
    Landarzt; 1967 Jun; 43(17):818-23. PubMed ID: 5616518
    [No Abstract]   [Full Text] [Related]  

  • 6. [Conservative treatment of arteriosclerosis obliterans].
    Thiele P
    Z Gesamte Inn Med; 1979 May; 34(9):99-102. PubMed ID: 483943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V
    Minerva Med; 1975 Jan; 66(2):55-65. PubMed ID: 1113917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical, oscillographic and plethysmographic comparison before and after medical and surgical treatment of subjects with peripheral obliterating arteriopathy].
    Tardito E; Grassi T
    Minerva Med; 1971 May; 62(39):1971-80. PubMed ID: 5579735
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A; Borri P; Parravicini R
    Minerva Cardioangiol; 1975 Nov; 23(11):701-10. PubMed ID: 1223674
    [No Abstract]   [Full Text] [Related]  

  • 10. [Conservative therapy of obliterating diseases of the extremities].
    Nazarov GD; Lesniak GP
    Khirurgiia (Mosk); 1970 Jan; 46(1):24-8. PubMed ID: 5437199
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of lumbar sympathectomy, determined by electromagnetic rheometry, in occlusive arteriopathies in the aged].
    Vara Lopez R; Vara Thorbech R; Carranza Albarran O
    Prensa Med Argent; 1970 May; 57(9):429-30. PubMed ID: 5517597
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of the therapeutic activity of the -pyridyl-carbinol ester of clofibric acid].
    Silingardi V; Renzi R; Mora A; Di Prisco AU
    Minerva Med; 1973 Mar; 64(16):751-69. PubMed ID: 4704721
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of adrenalectomy and lumbar ganglionectomy in the therapy of chronic peripheral obliterating arteriopathy (C.P.O.A.) of the lower extremities].
    Guagliano G; Vittori C; Maurizio A; Taborelli R
    Minerva Chir; 1967 Feb; 22(4):159-70. PubMed ID: 6050194
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conservative treatment of arteriosclerosis obliterans of the lower limbs].
    Kancelarczyk WL; Rymaszewski Z
    Kardiol Pol; 1981; 24(8):571-7. PubMed ID: 6169868
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and plethysmographic evaluation in patients with peripheral arteriopathies treated with pyridinolcarbamate].
    Lucero Eseverri JA; Fajardo JD; Velles Aguirre L; Quijano E; Ciliberti E; Lucarelli R
    Prensa Med Argent; 1970 Apr; 57(8):394-8. PubMed ID: 5517707
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs].
    Argenteri A; Bagliani A; Borri P; Ugolini U
    Clin Ter; 1974 Aug; 70(3):281-91. PubMed ID: 4423739
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progress surveillance of limb artery occlusions].
    Bollinger A; Lüthy E
    Schweiz Med Wochenschr; 1966 Aug; 96(34):1094-8. PubMed ID: 5985858
    [No Abstract]   [Full Text] [Related]  

  • 20. Intermittent claudication and rest pain: physiologic concepts and therapeutic approaches.
    Coffman JD
    Prog Cardiovasc Dis; 1979; 22(1):53-72. PubMed ID: 379915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.